Is Lincoln Pharmaceuticals Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Lincoln Pharmaceuticals Ltd (LINCOLN.NS) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Lincoln Pharmaceuticals Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Lincoln Pharmaceuticals Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Lincoln Pharmaceuticals Ltd?

Muslim investors may consider investing in Lincoln Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Lincoln Pharmaceuticals Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Lincoln Pharmaceuticals Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Lincoln Pharmaceuticals Ltd updated?

The Shariah compliance status of Lincoln Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Lincoln Pharmaceuticals Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Lincoln Pharmaceuticals Ltd?

You can check the latest Shariah compliance status of Lincoln Pharmaceuticals Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Lincoln Pharmaceuticals Ltd LINCOLN.NS

₹643.50 ₹17.50 (2.65%) 1D

Last Updated: May 15, 12:00 AM·NSE

LINCOLN.NS Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: January 11, 2026

Report Source: 2026 2nd Quarter Report

Lincoln Pharmaceuticals Ltd. Stock Analysis LINCOLN.NS

India Health Care Micro Cap Report: Q2, 2026

Lincoln Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and sale of pharmaceutical products. The Company’s product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, SVP injectables, dry-powder suspensions, liquid injection, and pharma products. The company offers products for anti-infective, respiratory system, gynecology, cardio and CNS (central nervous system), antibacterial, dermatological infection, anti-diabetic, and anti-malaria. The firm is also engaged in building a portfolio of lifestyle and chronic segments, primarily in women’s healthcare and dermatology. The firm caters to approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia, and 26 states across India. The firm has two manufacturing facilities located in Mehsana and Khatraj, Gujarat.

Key Statistics of Lincoln Pharmaceuticals Ltd (LINCOLN.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹641.25₹665.45

Today's Open

₹661.00

Volume

39.54K

P/E Ratio (TTM)

16.15

52 Week Range

₹440.00₹733.00

Market Cap

12.84B

Avg. Volume

245.70K

Dividend Yield

0.27%

Financial Metrics & Statements of Lincoln Pharmaceuticals Ltd (LINCOLN.NS)

FAQ's for Lincoln Pharmaceuticals Ltd (LINCOLN.NS)

According to Musaffa’s Shariah screening methodology, Lincoln Pharmaceuticals Ltd (LINCOLN.NS) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.